Lifecore Biomedical, Inc. De (LFCR) Asset Utilization Ratio (2011 - 2025)

Lifecore Biomedical's Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.54 for Q2 2025.

• In Q2 2025, Asset Utilization Ratio rose 5.35% year-over-year to 0.54; the TTM figure through May 2025 stood at 0.54 (up 5.35% YoY), while the FY2025 annual figure was 0.52, up 3.37% from the prior year.
• Asset Utilization Ratio was 0.54 for Q2 2025 at Lifecore Biomedical, up from 0.53 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.54 in Q2 2025 to a low of 0.24 in Q2 2021.
• Historically, Asset Utilization Ratio has averaged 0.42 across 5 years, with a median of 0.42 in 2023.
• The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio slumped 83.12% in 2021, then surged 65.85% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.28 in 2021, then soared by 44.16% to 0.4 in 2022, then rose by 13.83% to 0.46 in 2023, then gained by 13.97% to 0.52 in 2024, then gained by 3.67% to 0.54 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.54 (Q2 2025), 0.53 (Q1 2025), and 0.52 (Q4 2024), per Business Quant data.